Protective effect of glutamic acid on cardiac function and metabolism during cardioplegia and reperfusion. 1983

O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov

The effect of glutamic acid added to cardioplegic solution containing 20 mM K+ on the cardiac function and metabolism was studied in isolated working rat hearts. 30-min cardiac arrest resulted in profound fall in creatine phosphate and ATP content, by four- and two-fold, respectively, as well as in four-fold rise in AMP content. Simultaneously, during cardioplegia a decline in tissue glutamate and aspartate content and an increase in tissue ammonia and alanine content were found. After reperfusion, an incomplete restoration of ATP, AMP, and creatine phosphate content were observed; the cardiac output recovered only to 39 percent of the initial value. An addition of glutamic acid to cardioplegic solution was associated with significantly less decline in the content of high-energy phosphates and less prominent rise in AMP content during cardioplegia. It also prevented the decline in tissue aspartate content and caused a lesser ammonia accumulation in myocardial tissue due to the activation of glutamine synthesis. In spite of this the tissue ammonia level remained elevated. Reperfusion with Krebs-Henseleit buffer resulted in the recovery of cardiac output to 75% of the initial value as well as better restoration of high-energy phosphate content. The addition of glutamic acid in the perfusate during reperfusion led to further improvement of ATP and creatine phosphate content. It is suggested that an addition of glutamic acid may have beneficial effect in open heart surgery.

UI MeSH Term Description Entries
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
November 1988, Journal of molecular and cellular cardiology,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
December 1985, Pflugers Archiv : European journal of physiology,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
January 1990, Grudnaia i serdechno-sosudistaia khirurgiia,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
January 1991, Basic research in cardiology,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
January 1997, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
September 1987, The Canadian journal of cardiology,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
January 1986, Clinical science (London, England : 1979),
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
April 1950, Pediatrics,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
May 2019, Iranian journal of basic medical sciences,
O I Pisarenko, and E S Solomatina, and I M Studneva, and V E Ivanov, and V I Kapelko, and V N Smirnov
January 1992, Chinese medical journal,
Copied contents to your clipboard!